BioPlus ApS: Financial statements 2018
CVR: 37630683
Source: annual report 2018, Danish Business Authority
01/07/2017 – 30/06/2018
BioPlus ApS (CVR 37630683) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 200,000 and a net result of DKK 126,128. Equity in the 2018 report amounted to DKK 177,072. The solvency ratio was 83.2%.
- Gross Profit
- DKK 200,000
- Profit/Loss
- DKK 126,128
- Equity
- DKK 177,072
- Total Assets
- DKK 212,912
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
BioPlus ApS has published its interim report for the period April 15, 2016 – June 30, 2017.
As of April 9, 2018, Carsten Jensen is registered as director of BioPlus ApS.
As of February 6, 2018, Carsten Jensen has stepped down as adm. dir. of BioPlus ApS.
About BioPlus ApS
BioPlus ApS was a Danish company of the type Anpartsselskab based in Kastrup, founded in 2016. The company has been dissolved on 26 January 2022. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. In 2019, the company reported a gross profit of DKK -112,409 and a net result of DKK -117,681 compared with DKK 126,128 the year before. Equity in the 2019 report amounted to DKK 59,391.